Characteristic | All | Citrate | Heparin | Both | p |
---|---|---|---|---|---|
Patients | 282 | 75 (27%) | 79 (28%) | 128 (45%) | |
Age | 68 ± 13 | 67 ± 12 | 69 ± 14 | 69 ± 14 | 0.25 |
Dialysis per patientb | 6 ± 7 | 4 ± 4 | 4 ± 4 | 9 ± 9 | < 0.001 |
Female | 101 (36%) | 28 (37%) | 30 (38%) | 43 (34%) | 0.89 |
Race | |||||
White | 256 (91%) | 68 (91%) | 73 (92%) | 115 (90%) | 0.99 |
Asian | 5 (2%) | 3 (4%) | 0 | 2 (2%) | |
Arab | 20 (7%) | 4 (5%) | 0 | 10 (7%) | |
Black | 1 (0,3%) | 0 | 6 (8%) | 1 (1%) | |
Sepsis | 122 (43%) | 26 (35%) | 34 (43%) | 62 (48%) | 0.36 |
Liver cirrhosis | 18 (6%) | 9 (12%) | 3 (4%) | 6 (5%) | 0.07 |
ARF | 227 (80%) | 60 (80%) | 71 (90%) | 96 (75%) | 0.49 |
Anuria/oliguria | 153 (67%) | 37 (62%) | 45 (63%) | 71 (74%) | 0.51 |
MOF | 19 (25%) | 32 (33%) | 24 (30%) | 50 (39%) | 0.54 |
Invasive mechanical ventilation | 213 (76%) | 51 (68%) | 54 (68%) | 108 (84%) | 0.31 |
Needs of catecholamine | 202 (72%) | 50 (67%) | 51 (65%) | 101 (79%) | 0.44 |
Time of hospitalization (day)a | 18 (8-32) | 14 (4-29) | 14 (6-26) | 22 (11-40) | < 0.001 |
SAPS II score | 44 ± 14 | 45 ± 14 | 42 ± 13 | 44 ± 14 | 0.504 |
In-hospital mortality | 138 (49%) | 34 (45%) | 34 (43%) | 70 (55%) | 0.42 |